Por Galtec | octubre 30, 2023
Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology
Nadia Bannoud, Juan C Stupirski, Alejandro J Cagnoni, Pablo F Hockl, Juan M Pérez Sáez, P Alfredo García, Yamil D Mahmoud, Julián Gambarte Tudela, Marco A Scheidegger, Andrea Marshall, Pippa G Corrie, Mark R Middleton, Karina V Mariño, M Romina Girotti, Diego O Croci, Gabriel A Rabinovich